Get the Stockscreener App
1.30
7.14%
-0.10
Skye Bioscience Inc Stock (SKYE) Forecast
The Skye Bioscience Inc (SKYE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $12.82, representing a +885.96% increase from the current price of $1.30. The highest analyst price target is $14.69, and the lowest is $10.94.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SKYE Price Target
Average 13.04
(+902.70% Upside)
Is Skye Bioscience Inc (SKYE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 27.03 | Buy |
| STOCH(9,6) | 6.5978 | Buy |
| STOCHRSI(14) | 3.4238 | Buy |
| MACD(12,26) | -0.3474 | Sell |
| ADX(14) | 30.43 | Sell |
| William %R | -93.76 | Buy |
| CCI(14) | -103.77 | Sell |
Buy: 4
Sell: 3
Neutral: 0
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.812
Sell
|
1.70
Sell
|
| MA20 |
2.1017
Sell
|
1.9958
Sell
|
| MA50 |
2.602
Sell
|
2.4733
Sell
|
| MA100 |
3.0883
Sell
|
3.2126
Sell
|
| MA200 |
4.3056
Sell
|
5.0829
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, SKYE could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 13 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on SKYE, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 27.03 indicates that SKYE is oversold. This indicates that SKYE price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 6.5978 indicates that SKYE is oversold. This indicates that SKYE price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 3.4238 indicates that SKYE is oversold. This suggests that SKYE price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 30.43 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -103.77 indicates that SKYE is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term SKYE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Skye Bioscience Inc financial reports and earnings history, Skye Bioscience Inc (SKYE) stock could reach $10.46 by 2030, $6.4212 by 2040 and $18.90 by 2050. See the projected annual prices until 2050 of the Skye Bioscience Inc stock below:
- Skye Bioscience Inc (SKYE) is expected to reach an average price of $0.65 in 2035, with a high prediction of $4.2323 and a low estimate of $0.8201. This indicates an $-50.00% rise from the last recorded price of $1.30.
- Skye Bioscience Inc (SKYE) stock is projected to chart a bullish course in 2040, with an average price target of $6.89, representing an $430.00% surge from its current level. The forecast ranges from a conservative $7.0137 to a sky-high $6.4212.
- Our analysts predict Skye Bioscience Inc (SKYE) to jump 657.81% by 2045, soaring from $13.21 to an average price of $9.8516, potentially reaching $12.66. While $13.21 is the low estimate, the potential upside is significant.
- Skye Bioscience Inc (SKYE) stock is expected to climb by 2050, reaching an average of $19.16, a $1,374% jump from its current level. However, a wide range of estimates exists, with high and low targets of $18.90 and $19.40, respectively, highlighting the market's uncertainty.
Skye Bioscience Inc Stock (SKYE) Year by Year Forecast
Skye Bioscience Inc Stock (SKYE) Price Forecast for 2025
Skye Bioscience Inc Stock (SKYE) is expected to reach an average price of $13.45 in 2025, with a high prediction of $16.69 and a low estimate of $10.22. This indicates an +934.97% rise from the last recorded price of $1.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $11.47 | $10.94 | $14.69 | +782.31% |
| June, 2025 | $13.63 | $11.04 | $16.21 | +948.18% |
| July, 2025 | $13.46 | $10.82 | $16.09 | +935.01% |
| August, 2025 | $11.26 | $10.70 | $15.97 | +766.11% |
| September, 2025 | $11.21 | $10.58 | $15.85 | +762.05% |
| October, 2025 | $11.09 | $10.46 | $15.73 | +752.86% |
| November, 2025 | $14.10 | $10.34 | $15.61 | +984.91% |
| December, 2025 | $13.98 | $10.22 | $15.49 | +975.69% |
Skye Bioscience Inc Stock (SKYE) Price Forecast for 2026
The predicted value for Skye Bioscience Inc (SKYE) in 2026 is set at an average of $12.20. Estimates vary from a peak of $15.37 to a trough of $9.0201, indicating an +838.14% surge from the present price of $1.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $10.63 | $10.10 | $13.86 | +717.69% |
| February, 2026 | $12.79 | $10.20 | $15.37 | +883.68% |
| March, 2026 | $10.54 | $9.9801 | $15.25 | +711.03% |
| April, 2026 | $10.42 | $9.8601 | $15.13 | +701.85% |
| May, 2026 | $10.37 | $9.7401 | $15.01 | +697.68% |
| June, 2026 | $13.39 | $9.6201 | $14.89 | +929.63% |
| July, 2026 | $13.27 | $9.5001 | $14.77 | +920.41% |
| August, 2026 | $9.91 | $9.3801 | $13.14 | +662.31% |
| September, 2026 | $9.79 | $9.2601 | $14.65 | +653.08% |
| October, 2026 | $11.95 | $9.3658 | $14.53 | +819.19% |
| November, 2026 | $9.7081 | $9.1401 | $14.41 | +646.77% |
| December, 2026 | $9.5887 | $9.0201 | $14.29 | +637.60% |
Skye Bioscience Inc Stock (SKYE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Skye Bioscience Inc (SKYE) is $10.94, with a high forecast of $14.17 and a low forecast of $7.7001. This indicates an +741.30% increase from the last price of $1.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.5329 | $8.9001 | $14.17 | +633.30% |
| February, 2027 | $12.55 | $8.7801 | $14.05 | +865.13% |
| March, 2027 | $12.43 | $8.6601 | $13.93 | +855.92% |
| April, 2027 | $9.07 | $8.5401 | $12.30 | +597.69% |
| May, 2027 | $11.23 | $8.6471 | $13.81 | +763.91% |
| June, 2027 | $11.06 | $8.4201 | $13.69 | +750.57% |
| July, 2027 | $8.8728 | $8.3001 | $13.57 | +582.52% |
| August, 2027 | $8.8156 | $8.1801 | $13.46 | +578.12% |
| September, 2027 | $8.6961 | $8.0601 | $13.34 | +568.93% |
| October, 2027 | $11.71 | $7.9401 | $13.22 | +800.63% |
| November, 2027 | $8.35 | $7.8201 | $11.59 | +542.31% |
| December, 2027 | $8.23 | $7.7001 | $13.10 | +533.08% |
Skye Bioscience Inc Stock (SKYE) Price Forecast for 2028
In 2028, Skye Bioscience Inc (SKYE) is projected to reach an average price of $9.7381, with a high projection of $12.98 and a low estimate of $6.5001. This indicates an +649.08% rise from the last price of $1.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $10.39 | $7.8087 | $12.98 | +699.41% |
| February, 2028 | $8.1568 | $7.5801 | $12.86 | +527.44% |
| March, 2028 | $8.0374 | $7.4601 | $12.74 | +518.26% |
| April, 2028 | $7.9787 | $7.3401 | $12.62 | +513.75% |
| May, 2028 | $7.8592 | $7.2201 | $12.50 | +504.55% |
| June, 2028 | $10.87 | $7.1001 | $12.38 | +736.14% |
| July, 2028 | $7.51 | $6.9801 | $10.75 | +477.69% |
| August, 2028 | $7.39 | $6.8601 | $12.26 | +468.46% |
| September, 2028 | $9.5539 | $6.9703 | $12.14 | +634.92% |
| October, 2028 | $7.3215 | $6.7401 | $12.02 | +463.19% |
| November, 2028 | $7.2021 | $6.6201 | $11.90 | +454.01% |
| December, 2028 | $7.1419 | $6.5001 | $11.78 | +449.37% |
Skye Bioscience Inc Stock (SKYE) Price Forecast for 2029
The 2029 price forecast for Skye Bioscience Inc Stock (SKYE) is $8.4793 on average, with a high prediction of $11.66 and a low estimate of $5.3001. This represents an +552.25% increase from the previous price of $1.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.0223 | $6.3801 | $11.66 | +440.18% |
| February, 2029 | $10.03 | $6.2601 | $11.54 | +671.64% |
| March, 2029 | $6.67 | $6.1401 | $9.9128 | +413.08% |
| April, 2029 | $8.8353 | $6.2516 | $11.42 | +579.63% |
| May, 2029 | $8.6596 | $6.0201 | $11.30 | +566.12% |
| June, 2029 | $6.4861 | $5.9001 | $11.18 | +398.93% |
| July, 2029 | $6.4245 | $5.7801 | $11.06 | +394.20% |
| August, 2029 | $6.305 | $5.6601 | $10.94 | +385.00% |
| September, 2029 | $9.3127 | $5.5401 | $10.82 | +616.36% |
| October, 2029 | $9.1929 | $5.4201 | $10.70 | +607.15% |
| November, 2029 | $5.83 | $5.3001 | $9.0759 | +348.46% |
| December, 2029 | $7.9968 | $5.4132 | $10.58 | +515.14% |
Skye Bioscience Inc Stock (SKYE) Price Forecast for 2030
Skye Bioscience Inc Stock (SKYE) is expected to reach an average price of $7.2204 in 2030, with a high forecast of $10.46 and a low forecast of $3.9801. This signifies an +455.41% surge from the last price of $1.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.8204 | $5.1801 | $10.46 | +501.57% |
| February, 2030 | $5.6508 | $5.0601 | $10.34 | +334.68% |
| March, 2030 | $5.5877 | $4.9401 | $10.22 | +329.82% |
| April, 2030 | $8.5941 | $4.8201 | $10.10 | +561.08% |
| May, 2030 | $8.4743 | $4.7001 | $9.9816 | +551.87% |
| June, 2030 | $5.11 | $4.5801 | $8.3586 | +293.08% |
| July, 2030 | $4.99 | $4.4601 | $9.8618 | +283.85% |
| August, 2030 | $7.1584 | $4.5747 | $9.742 | +450.64% |
| September, 2030 | $4.9348 | $4.3401 | $9.6222 | +279.60% |
| October, 2030 | $4.8155 | $4.2201 | $9.5025 | +270.42% |
| November, 2030 | $4.7508 | $4.1001 | $9.3827 | +265.45% |
| December, 2030 | $7.7556 | $3.9801 | $9.2629 | +496.59% |
10.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):